The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shestakova M.V.

Institut diabeta Éndokrinologicheskogo nauchnogo tsentra, Moskva

Sklyanik I.A.

Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia;
M.V. Lomonosov Moscow State University, Moscow, Russia

Dedov I.I.

Endocrinology Research Centre

Is it possible to achieve sustained remission or cure of type 2 diabetes mellitus in the 21st century?

Authors:

Shestakova M.V., Sklyanik I.A., Dedov I.I.

More about the authors

Journal: Therapeutic Archive. 2017;89(10): 4‑11

DOI: 10.17116/terarkh201789104-11

Read: 51385 times

Download PDF (RU)
Contact the author
Table of contents

IS IT POSSIBLE TO ACHIEVE SUSTAINED REMISSION OR CURE OF TYPE 2 DIABETES MELLITUS IN THE 21ST CENTURY?
IS IT POSSIBLE TO ACHIEVE SUSTAINED REMISSION OR CURE OF TYPE 2 DIABETES MELLITUS IN THE 21ST CENTURY?

To cite this article:

Shestakova MV, Sklyanik IA, Dedov II. Is it possible to achieve sustained remission or cure of type 2 diabetes mellitus in the 21st century? Therapeutic Archive. 2017;89(10):4‑11. (In Russ.)
https://doi.org/10.17116/terarkh201789104-11

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Options for the surgical technique of lapa­roscopic sleeve gastrectomy for prevention and treatment of gastroesophageal reflux in patients with obesity. Endo­scopic Surgery. 2024;(6):57-68
The role of quantitative body composition analysis in popu­lation in the asse­ssment and moni­toring of cardiovascular risk meta­bolic factors. Russian Journal of Preventive Medi­cine. 2024;(12):128-134
Restoration of spermatogenesis suppressed by the use of testosterone, antiestrogen therapy in men with type 2 diabetes mellitus. Russian Journal of Human Reproduction. 2024;(6):156-160
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50
Features of comprehensive treatment in a patient with complicated type 2 diabetes mellitus: A clinical case. Piro­gov Russian Journal of Surgery. 2025;(6):128-132
Early diagnosis and effe­ctive therapy of diabetic poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68
Hype­rtensive diso­rders of pregnancy as a risk factor for chro­nic non-communicable diseases. Russian Journal of Preventive Medi­cine. 2025;(6):114-119
Cere­brovascular disease in clinical practice. Reso­lution of the Expert Council of the Russian Scientific Medi­cal Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):105-111
Abstract:

A practitioner has a wide range of the hypoglycemic drugs for type 2 diabetes mellitus (T2DM) treatment, which can be used within a normal or near-normal range for long-term glycemic control. However, the question remains whether there are ways to achieve not only satisfactory glycemic control, but also T2DM remission (or even complete cure). The review presents an update on the concept of T2DM remission and describes the ways of its possible achievement with non-drug and drug treatments and surgery. The mechanisms of T2DM remission are given.

Keywords:

diabetes mellitus
diabetes remission
weight loss
gastrointestinal hormones
metabolic surgery

Authors:

Shestakova M.V.

Institut diabeta Éndokrinologicheskogo nauchnogo tsentra, Moskva

Sklyanik I.A.

Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia;
M.V. Lomonosov Moscow State University, Moscow, Russia

Dedov I.I.

Endocrinology Research Centre

Close metadata

References:

  1. «WHO Fact sheet, Updated June 2016». Accessed May 11, 2017. Available at: http://www.who.int/mediacentre/factsheets/fs311
  2. WHO, «Global report on diabetes», World Health Organization, Geneva, 2016.
  3. Buse JB, Caprio S, Cefalu WT, et al. How Do We Define Cure of Diabetes? Diabetes Care. 2009;32(11):2133-2135. https://doi.org/10.2337/dc09-9036
  4. Dixon JB, Zimmet P, Alberti KG, Rubino F, International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28(6):628-642. https://doi.org/10.1111/j.1464-5491.2011.03306.x
  5. UKPDS Group, «United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Pro». Ann Intern Med. 1998;128(3):165-175.
  6. Viberti G, Kahn SE, Greene DA, et al. A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care. 2002;25(10): 1737-1743. https://doi.org/10.2337/diacare.25.10.1737
  7. Gregg EW, Chen H, Wagenknecht LE, et al. Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes. JAMA. 2012;308(23):2489-2496. https://doi.org/10.1001/jama.2012.67929
  8. Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care. 2016;39(5):808-815. https://doi.org/10.2337/dc15-1942
  9. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506-2514. https://doi.org/10.1007/s00125-011-2204-7
  10. Kirk E, Reeds DN, Finck BN, Mayurranjan MS, Patterson BW, Klein S. Dietary Fat and Carbohydrates Differentially Alter Insulin Sensitivity During Caloric Restriction. Gastroenterology. 2009;136(5):1552-1560. https://doi.org/10.1053/j.gastro.2009.01.048
  11. National Institute of Diabetes and Digestive and Kidney Diseases. Very Low-Calorie Diets.; 2012. https://www.niddk.nih.gov/health-information/health-topics/weight-control/very-low-calorie-diets/Pages/very-low-calorie-diets.aspx
  12. Vettor R, Serra R, Fabris R, Pagano C, Federspil G. Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies. Diabetes Care. 2005;28(4):942-949. https://doi.org/10.2337/diacare.28.4.942
  13. Miles JM, Leiter L, Hollander P, et al. Effect of Orlistat in Overweight and Obese Patients With Type 2 Diabetes Treated With Metformin. Diabetes Care. 2002;25(7):1123-1128. https://doi.org/10.2337/diacare.25.7.1123
  14. Madsbad S, Lieberman G, Skjoth T, Lilleore S, DeFronzo R. Abstracts of 52nd EASD Annual Meeting. Comparable efficacy and safety of liraglutide 3.0 mg for weight management across baseline BMI subgroups: results from the SCALE obesity and prediabetes trial. Diabetologia. 2016;59:1-581. https://doi.org/10.1007/s00125-016-4046-9
  15. Ershova EV, Yashkov YI. Status of carbohydrate and lipid metabolism in obese patients with type 2 diabetes mellitus after biliopancreatic diversion surgery. Obe Metab. 2013;(3):28-36. (In Russ.)
  16. Frühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015;11(8):465-477. https://doi.org/10.1038/nrendo.2015.84
  17. Dedov II, Shestakova MV, Mayorov AY, Vikulova OK, Galstyan GR, Kuraeva TL, et al. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition. Diabetes mellitus. 2017;20(1S):1-121. (In Russ.)
  18. Panuzi S, Mingrone G, Gaetano A, et al. Five-year outcomes after surgery and medical therapy for type 2 diabetes: a randomized clinical trial. In: 2nd Diabetes Surgery Summit — (DSS-II). UK: London; 2015.
  19. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349(9):g3961-g3961. https://doi.org/10.1136/bmj.g3961
  20. Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996;98(3):741-749. https://doi.org/10.1172/JCI118846
  21. Perry RJ, Camporez J-PG, Kursawe R, et al. Hepatic Acetyl CoA Links Adipose Tissue Inflammation to Hepatic Insulin Resistance and Type 2 Diabetes. Cell. 2015;160(4):745-758. https://doi.org/10.1016/j.cell.2015.01.012
  22. Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest. 2012;122(12):4667-4674. https://doi.org/10.1172/JCI64895
  23. Bradley D, Magkos F, Eagon JC, et al. Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects. Obesity. 2014;22(9):2026-2031. https://doi.org/10.1002/oby.20803
  24. Bojsen-Møller KN, Dirksen C, Jørgensen NB, et al. Early Enhancements of Hepatic and Later of Peripheral Insulin Sensitivity Combined With Increased Postprandial Insulin Secretion Contribute to Improved Glycemic Control After Roux-en-Y Gastric Bypass. Diabetes. 2014;63(5):1725-1737. https://doi.org/10.2337/db13-1307
  25. Plourde C-É, Grenier-Larouche T, Caron-Dorval D, et al. Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction. Obesity. 2014; 22(8):1838-1846. https://doi.org/10.1002/oby.20771
  26. Jackness C, Karmally W, Febres G, et al. Very Low-Calorie Diet Mimics the Early Beneficial Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity and Cell Function in Type 2 Diabetic Patients. Diabetes. 2013;62(9):3027-3032. https://doi.org/10.2337/db12-1762
  27. Lips MA, de Groot GH, van Klinken JB, et al. Calorie Restriction is a Major Determinant of the Short-Term Metabolic Effects of Gastric Bypass Surgery in Obese Type 2 Diabetic Patients. Clin Endocrinol (Oxf). 2014;80(6):834-842. https://doi.org/10.1111/cen.12254
  28. Foo J, Krebs J, Hayes MT, et al. Studies in Insulin Resistance following Very Low Calorie Diet and/or Gastric Bypass Surgery. Obes Surg. 2011;21(12):1914-1920. https://doi.org/10.1007/s11695-011-0527-6
  29. Ahrén B. Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives. Diabetes Metab. 2013;39(3):195-201. https://doi.org/10.1016/j.diabet.2013.03.001
  30. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: Mechanisms of Diabetes Remission and Role of Gut Hormones. J Clin Endocrinol Metab. 2013;98(11):4391-4399. https://doi.org/10.1210/jc.2013-2538
  31. Falkén Y, Hellström PM, Holst JJ, Näslund E. Changes in Glucose Homeostasis after Roux-en-Y Gastric Bypass Surgery for Obesity at Day Three, Two Months, and One Year after Surgery: Role of Gut Peptides. J Clin Endocrinol Metab. 2011;96(7):2227-2235. https://doi.org/10.1210/jc.2010-2876
  32. Martinussen C, Bojsen-Møller KN, Dirksen C, et al. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass. Am J Physiol Endocrinol Metab. 2015;308(6):E535-E544. https://doi.org/10.1152/ajpendo.00506.2014
  33. Tsoli M, Chronaiou A, Kehagias I, Kalfarentzos F, Alexandrides TK. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis. 2013;9(5):667-677. https://doi.org/10.1016/j.soard.2012.12.006
  34. Romero F, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26(8):2231-2239. https://doi.org/10.1007/s00464-012-2166-y
  35. Manning S, Pucci A, Batterham RL. GLP-1: A Mediator of the Beneficial Metabolic Effects of Bariatric Surgery? Physiology. 2015;30(1):50-62. https://doi.org/10.1152/physiol.00027.2014
  36. Mumphrey MB, Patterson LM, Zheng H, Berthoud H-R. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil. 2013;25(1):e70-e79. https://doi.org/10.1111/nmo.12034
  37. Dutia R, Brakoniecki K, Bunker P, et al. Limited Recovery of Cell Function After Gastric Bypass Despite Clinical Diabetes Remission. Diabetes. 2014;63(4):1214-1223. https://doi.org/10.2337/db13-1176
  38. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin Enhances Appetite and Increases Food Intake in Humans. J Clin Endocrinol Metab. 2001;86(12):5992-5992. https://doi.org/10.1210/jcem.86.12.8111
  39. Engelstoft MS, Schwartz TW. Opposite Regulation of Ghrelin and Glucagon-like Peptide-1 by Metabolite G-Protein-Coupled Receptors. Trends Endocrinol Metab. 2016;27(9):665-675. https://doi.org/10.1016/j.tem.2016.07.001
  40. Quercia I, Dutia R, Kotler DP, Belsley S, Laferrère B. Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014; 40(2):87-94. https://doi.org/10.1016/j.diabet.2013.11.003
  41. Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and Hormonal Changes After Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: a Randomized, Prospective Trial. Obes Surg. 2012;22(5):740-748. https://doi.org/10.1007/s11695-012-0622-3
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.